Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-ADCs and PROTACs-PROTAC-AF151
AF151

Chemical Structure : AF151

CAS No.:

AF151 (AF-151)

Catalog No.: PC-28783Not For Human Use, Lab Use Only.

AF151 is a potent, efficient, VHL-based METTL3 PROTAC degrader with DC50 of 430 nM in AML cell line MOLM-13, Dmax=95%.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

AF151 is a potent, efficient, VHL-based METTL3 PROTAC degrader with DC50 of 430 nM in AML cell line MOLM-13, Dmax=95%.
AF151 induces rapid METTL3 degradation, achieving over 50% METTL3 reduction within the first 6 h of treatment, reaching maximal effect at 24 h, and maintaining it for at least 48 h.
AF151 binds to the SAM-binding site of METTL3, shows high VHL affinity with KD of 363 nM.
AF151 is able to form a stable ternary complex between VHL and METTL3, exhibiting positive cooperativity and effectively reducing METTL3 levels in MOLM-13 cells in a concentration-, time-, and UPS-dependent manner.
AF151 reduces cell viability with IC50 of 0.45 uM in MOLM-13 cells, effectively promotes apoptosis in cancer cell lines, induces pronounced m6A reduction than the competitive inhibitor STM245.
AF151 is sensitizing MOLM-13 cells for treatment with venetoclax as the apoptosis-inducing effector, possibly by downregulation of Bcl-2 family proteins.

Physicochemical Properties

M.Wt 1043.34
Formula C61H70N8O6S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-((2-((4,4-dimethylpiperidin-1-yl)methyl)-1H-indol-6-yl)methyl)-5-((4'-(3-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-3-oxopropyl)-[1,1'-biphenyl]-4-yl)methoxy)nicotinamide

References

1. Weldert AC, et al. RSC Med Chem. 2025 Jun 19;16(9):4194-4207.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: